BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32993115)

  • 1. Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia.
    Mohanty S; Jyotsana N; Sharma A; Kloos A; Gabdoulline R; Othman B; Lai CK; Schottmann R; Mandhania M; Schmoellerl J; Grebien F; Ramsay E; Thomas A; Vornlocher HP; Ganser A; Thol F; Heuser M
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32993115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
    Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.
    Thanasopoulou A; Tzankov A; Schwaller J
    Haematologica; 2014 Sep; 99(9):1465-71. PubMed ID: 24951466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dasatinib and navitoclax act synergistically to target NUP98-NSD1
    Kivioja JL; Thanasopoulou A; Kumar A; Kontro M; Yadav B; Majumder MM; Javarappa KK; Eldfors S; Schwaller J; Porkka K; Heckman CA
    Leukemia; 2019 Jun; 33(6):1360-1372. PubMed ID: 30568173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.
    Miyajima T; Onozawa M; Yoshida S; Miyashita N; Kimura H; Takahashi S; Yokoyama S; Matsukawa T; Goto H; Sugita J; Fujisawa S; Hidaka D; Ogasawara R; Mori A; Matsuoka S; Shigematsu A; Wakasa K; Kasahara I; Saga T; Hashiguchi J; Takeda Y; Ibata M; Yutaka T; Fujimoto K; Kondo T; Teshima T
    Eur J Haematol; 2023 Oct; 111(4):620-627. PubMed ID: 37465857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia.
    Shiba N; Ichikawa H; Taki T; Park MJ; Jo A; Mitani S; Kobayashi T; Shimada A; Sotomatsu M; Arakawa H; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
    Genes Chromosomes Cancer; 2013 Jul; 52(7):683-93. PubMed ID: 23630019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.
    Ostronoff F; Othus M; Gerbing RB; Loken MR; Raimondi SC; Hirsch BA; Lange BJ; Petersdorf S; Radich J; Appelbaum FR; Gamis AS; Alonzo TA; Meshinchi S
    Blood; 2014 Oct; 124(15):2400-7. PubMed ID: 25145343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic characteristics and clinical outcomes of pediatric acute myeloid leukemia with NUP98-NSD1 fusion gene].
    Wang T; Ni JB; Wang XY; Dai Y; Ma XL; Su YC; Gao YY; Chen X; Yuan LL; Liu HX
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2820-2825. PubMed ID: 31550809
    [No Abstract]   [Full Text] [Related]  

  • 9. The Nup98::Nsd1 fusion gene induces CD123 expression in 32D cells.
    Okamoto K; Imamura T; Tanaka S; Urata T; Yoshida H; Shiba N; Iehara T
    Int J Hematol; 2023 Aug; 118(2):277-287. PubMed ID: 37173550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation.
    Jevtic Z; Matafora V; Casagrande F; Santoro F; Minucci S; Garre' M; Rasouli M; Heidenreich O; Musco G; Schwaller J; Bachi A
    J Exp Clin Cancer Res; 2022 Jan; 41(1):34. PubMed ID: 35073946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutated
    Niktoreh N; Walter C; Zimmermann M; von Neuhoff C; von Neuhoff N; Rasche M; Waack K; Creutzig U; Hanenberg H; Reinhardt D
    J Oncol; 2019; 2019():1609128. PubMed ID: 31467532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upfront Screening by Quantitative Real-Time PCR Assay Identifies NUP98::NSD1 Fusion Transcript in Indian AML Patients.
    Shah A; Sharma A; Katiyar S; Gupta A; Chaturvedi CP
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553008
    [No Abstract]   [Full Text] [Related]  

  • 13. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial.
    Shiba N; Ohki K; Kobayashi T; Hara Y; Yamato G; Tanoshima R; Ichikawa H; Tomizawa D; Park MJ; Shimada A; Sotomatsu M; Arakawa H; Horibe K; Adachi S; Taga T; Tawa A; Hayashi Y
    Br J Haematol; 2016 Feb; 172(4):581-91. PubMed ID: 26684393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
    Wang GG; Cai L; Pasillas MP; Kamps MP
    Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular Characteristics and Clinical Features of Adults with
    Lun Y; Huang JC; Long D; Wang FF; Dai Y; Yang Y; Zhao TT; Li Q; Wu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):575-581. PubMed ID: 30378313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia.
    Kivioja JL; Lopez Martí JM; Kumar A; Kontro M; Edgren H; Parsons A; Lundán T; Wolf M; Porkka K; Heckman CA
    Leuk Lymphoma; 2018 Mar; 59(3):725-732. PubMed ID: 28776436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MLL-Menin Interaction is a Therapeutic Vulnerability in
    Rasouli M; Blair H; Troester S; Szoltysek K; Cameron R; Ashtiani M; Krippner-Heidenreich A; Grebien F; McGeehan G; Zwaan CM; Heidenreich O
    Hemasphere; 2023 Aug; 7(8):e935. PubMed ID: 37520776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
    Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
    Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions.
    Mitani Y; Hiwatari M; Seki M; Hangai M; Takita J
    Int J Hematol; 2019 Oct; 110(4):512-516. PubMed ID: 31134509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.
    Schmoellerl J; Barbosa IAM; Eder T; Brandstoetter T; Schmidt L; Maurer B; Troester S; Pham HTT; Sagarajit M; Ebner J; Manhart G; Aslan E; Terlecki-Zaniewicz S; Van der Veen C; Hoermann G; Duployez N; Petit A; Lapillonne H; Puissant A; Itzykson R; Moriggl R; Heuser M; Meisel R; Valent P; Sexl V; Zuber J; Grebien F
    Blood; 2020 Jul; 136(4):387-400. PubMed ID: 32344427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.